122 related articles for article (PubMed ID: 2605787)
1. Different hepatic responses to thyroxine replacement in spontaneous and 131I-induced primary hypothyroidism.
Gow SM; Caldwell G; Toft AD; Beckett GJ
Clin Endocrinol (Oxf); 1989 May; 30(5):505-12. PubMed ID: 2605787
[TBL] [Abstract][Full Text] [Related]
2. Relationship between pituitary and other target organ responsiveness in hypothyroid patients receiving thyroxine replacement.
Gow SM; Caldwell G; Toft AD; Seth J; Hussey AJ; Sweeting VM; Beckett GJ
J Clin Endocrinol Metab; 1987 Feb; 64(2):364-70. PubMed ID: 3793854
[TBL] [Abstract][Full Text] [Related]
3. Restoration of normal thyrotrophin secretion reduces the abnormally high serum glutathione S-transferase levels found in patients receiving thyroxine replacement therapy.
Gow SM; Caldwell G; Toft AD; Sweeting VM; Beckett GJ
Clin Endocrinol (Oxf); 1988 Sep; 29(3):249-56. PubMed ID: 3251666
[TBL] [Abstract][Full Text] [Related]
4. Raised plasma glutathione S-transferase values in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: evidence for hepatic damage.
Beckett GJ; Kellett HA; Gow SM; Hussey AJ; Hayes JD; Toft AD
Br Med J (Clin Res Ed); 1985 Aug; 291(6493):427-31. PubMed ID: 3926229
[TBL] [Abstract][Full Text] [Related]
5. Thyroxine replacement in post-radioiodine hypothyroidism.
Bearcroft CP; Toms GC; Williams SJ; Noonan K; Monson JP
Clin Endocrinol (Oxf); 1991 Feb; 34(2):115-8. PubMed ID: 2022062
[TBL] [Abstract][Full Text] [Related]
6. Determination of replacement and suppressive doses of thyroxine.
Banovac K; Carrington SA; Levis S; Fill MD; Bilsker MS
J Int Med Res; 1990; 18(3):210-8. PubMed ID: 2361563
[TBL] [Abstract][Full Text] [Related]
7. Effect of replacement doses of thyroxine on bone mineral density.
Hanna FW; Pettit RJ; Ammari F; Evans WD; Sandeman D; Lazarus JH
Clin Endocrinol (Oxf); 1998 Feb; 48(2):229-34. PubMed ID: 9579237
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
9. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
[TBL] [Abstract][Full Text] [Related]
10. Levothyroxine dose requirements for thyrotropin suppression in the treatment of differentiated thyroid cancer.
Burmeister LA; Goumaz MO; Mariash CN; Oppenheimer JH
J Clin Endocrinol Metab; 1992 Aug; 75(2):344-50. PubMed ID: 1639933
[TBL] [Abstract][Full Text] [Related]
11. Serum iodothyronine concentrations during introduction of thyroxine replacement therapy in hypothyroidism.
Pearce CJ; Himsworth RL
Clin Endocrinol (Oxf); 1986 Sep; 25(3):303-11. PubMed ID: 3791670
[TBL] [Abstract][Full Text] [Related]
12. Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal.
Vaiano A; Claudio Traino A; Boni G; Grosso M; Lazzeri P; Colato C; Davì MV; Francia G; Lazzeri M; Mariani G; Ferdeghini M
Nucl Med Commun; 2007 Mar; 28(3):215-23. PubMed ID: 17264781
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
[TBL] [Abstract][Full Text] [Related]
14. Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients.
Targher G; Montagnana M; Salvagno G; Moghetti P; Zoppini G; Muggeo M; Lippi G
Clin Endocrinol (Oxf); 2008 Mar; 68(3):481-4. PubMed ID: 17941901
[TBL] [Abstract][Full Text] [Related]
15. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
Konno N; Morikawa K
J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
[TBL] [Abstract][Full Text] [Related]
16. Lessons to be learned: a case study approach: severe hyponatraemia induced by primary hypothyroidism and associated with possible increased hepatic sensitivity to thyroxine replacement.
Olukoga A; Horsman G; Stewart F
J R Soc Promot Health; 1999 Jun; 119(2):117-20. PubMed ID: 11043008
[TBL] [Abstract][Full Text] [Related]
17. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
18. Thyroxine replacement therapy and circulating lipid concentrations.
Franklyn JA; Daykin J; Betteridge J; Hughes EA; Holder R; Jones SR; Sheppard MC
Clin Endocrinol (Oxf); 1993 May; 38(5):453-9. PubMed ID: 8330440
[TBL] [Abstract][Full Text] [Related]
19. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.
Franklyn J; Betteridge J; Holder R; Daykin J; Lilley J; Sheppard M
Clin Endocrinol (Oxf); 1994 Oct; 41(4):425-32. PubMed ID: 7955453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
